Facebook
Instagram
Linkedin
Youtube
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Search
BioStock
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Home
Tags
ELC-301
Tag: ELC-301
Elicera Therapeutics strengthens financial standing in Q2
30 August, 2022
Elicera receives funding for clinical trials with ELC-301
3 June, 2022
Elicera well-positioned to thrive in 2022
20 January, 2022
Elicera Therapeutics keeps strong momentum after IPO
24 November, 2021
Elicera Therapeutics takes immuno-oncology to the next level
2 March, 2021
1
2
Page 2 of 2